SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
荀誉
Lv1
50 积分
2021-08-09 加入
最近求助
最近应助
互助留言
Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy
16天前
已完结
Neoadjuvant-Adjuvant vs Neoadjuvant-Only PD-1 and PD-L1 Inhibitors for Patients With Resectable NSCLC
1个月前
已关闭
MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing Technology
1个月前
已完结
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions
4个月前
已完结
Individualized tumor-informed circulating tumor DNA analysis for postoperative monitoring of non-small cell lung cancer
5个月前
已完结
Molecular Profiling in Early ER + Breast Cancer to Aid Systemic Therapy Decisions
5个月前
已完结
Boosting the abscopal effect with chemoradiotherapy/immunotherapy combination in metastatic cervical cancer: a case report
5个月前
已完结
Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer
6个月前
已完结
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma
6个月前
已完结
Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial
7个月前
已完结
没有进行任何应助
下载到了【积分已退回】
1个月前
感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论